Octreotide Acetate Injection is a somatostatin analogue indicated: Acromegaly: To reduce blood levels of growth hormone (GH) and insulin growth factor-1 (IGF-1; somatomedin C) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses.
From the U.S. FDA-approved label for Octreotide. Full label: DailyMed.
Octreotide Acetate Injection is a somatostatin analogue indicated: Acromegaly: To reduce blood levels of growth hormone (GH) and insulin growth factor-1 (IGF-1; somatomedin C) in acromegaly patients who have had inadequate response to or cannot be treated with surgical resection, pituitary irradiation, and bromocriptine mesylate at maximally tolerated doses. Carcinoid Tumors: For the symptomatic treatment of patients with metastatic carcinoid tumors where it suppresses or inhibits the severe diarrhea and flushing episodes associated with the disease. Vasoactive Intestinal Peptide Tumors (VIPomas): For the treatment of profuse watery diarrhea associated with VIP-secreting tumors.
From the U.S. FDA-approved label for Octreotide. Full label: DailyMed.
Octreotide Acetate injection may be administered subcutaneously or intravenously. Acromegaly: Recommended initial Octreotide Acetate injection dosage is 50 mcg three times daily during the initial 2 weeks of therapy. Maintenance dose 100 mcg to 500 mcg three times daily.
Directions from the U.S. FDA-approved label — your doctor or pharmacist may advise differently.
Sensitivity to this drug or any of its components. Sensitivity to this drug or any of its components.
Excerpt from the U.S. FDA-approved label. Talk to a pharmacist or doctor before use.
Cardiac Function Abnormalities: Increased risk for higher degree of atrioventricular blocks. Consider cardiac monitoring in patients receiving octreotide acetate injection intravenously. Bradycardia, arrhythmias, or conduction abnormalities may occur. Use with caution in at-risk patients. Dosage adjustment of cardiac medications may be necessary. Cholelithiasis and Complications of Cholelithiasis: Monitor periodically. Discontinue if complications of cholelithiasis are suspected. Glucose Metabolism: Hypoglycemia or hyperglycemia may occur. Glucose monitoring is recommended and anti-diabetic treatment may need adjustment.
Warnings and precautions excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor before use.
The following clinically significant adverse reactions are described elsewhere in the labeling: Complete Atrioventricular Block Cholelithiasis and Complications of Cholelithiasis Hyperglycemia and Hypoglycemia Thyroid Function Abnormalities Steatorrhea and Malabsorption of Dietary Fats Changes in Vitamin B12 Levels Most common adverse reactions (incidence > 10%) in patients with acromegaly are gallbladder abnormalities, sinus…
Excerpt from the U.S. FDA-approved label — not a complete list. Talk to a pharmacist or doctor about side effects.
5 products from 2 makers in the NepalDoc medicine catalog use this generic:
| Brand | Composition | Maker | Pack |
|---|---|---|---|
| Octride 0.05%mg Injection | Octreotide (0.05%mg) | Sun Pharmaceutical Industries Ltd. | |
| Octride 0.1mg Injection | Octreotide (0.1mg) | Sun Pharmaceutical Industries Ltd. | |
| Octride 50 MCG Injection | Octreotide (50 MCG) | Sun Pharmaceutical Industries Ltd. | |
| Sandostatin 0.05%mg Injection | Octreotide (0.05%mg) | Novartis India Ltd. | |
| Sandostatin 0.1mg Injection | Octreotide (0.1mg) | Novartis India Ltd. |
Brand list from the NepalDoc medicine catalog. Availability varies by pharmacy — call ahead to confirm stock.
Storage, Octreotide Acetate Injection single-dose vials should be stored at refrigerated temperatures 2°C to 8°C (36°F to 46°F) and store in outer carton in order to protect from light.
Storage information from the U.S. FDA-approved label.
This page is information only and is not medical advice. Medicine details come from the sources listed above and may change — always confirm the medicine, strength and dose with a pharmacist or doctor before use. A catalog listing does not guarantee that a medicine is in stock at any pharmacy.
